Investor Relations

Trendlines invests in innovation-based medtech and agrifood technologies.

As intensely hands-on investors, we are involved in all aspects of our portfolio companies from technology development to business building.

Stock Information
For Corporate Governance please press the form Reset button.
09 Feb, 2026 Trendlines Portfolio Company Phytolon Achieves Major FDA Regulatory Milestone Paving the Way for Commercialization
03 Feb, 2026 December 2025 and January 2026 - Monthly Update
29 Jan, 2026 Closing of Management Transfer Agreement
19 Jan, 2026 Disclosure of Interests/Change of Interests of Director/CEO
19 Jan, 2026 Disclosure of Change of Interests of Substantial Shareholder - Librae Holdings
15 Jan, 2026 Completion of Placement
14 Jan, 2026 Listing and Quotation Notice Pursuant to the Proposed Placement
08 Jan, 2026 Update and Press Release following Private Placement Announcement
07 Jan, 2026 The Proposed Placement of up to 83,680,000 New Ordinary Shares
04 Jan, 2026 Portfolio Company Limaca Medical Announces Exclusive Distribution Agreement
02 Jan, 2026 Disclosure of Change of Interests of Substantial Shareholder
02 Jan, 2026 Disclosure of Change of Interests of Substantial Shareholder
Shira Zimmerman
Investor Communications
The Trendlines Group
investors@trendlines.com
Skip to content